We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) last year stopped criminals making more than £7.5 million linked to the illegal trade in medicines.
The consultation will set the future direction for the community pharmacy sector.
UKHSA confirms rare case of bird flu A(H5N1) in the West Midlands region.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 24 January 2025, approved garadacimab (brand name Andembry) for patients aged 12 years and older with hereditary angioedema (HAE) to prevent angioedem…
UKHSA publishes the latest human papillomavirus (HPV) vaccine coverage statistics in England
As part of its pledge to be transparent, IBCA will publish updates about the number of invites sent, claims processed and offers of compensation made
Infected Blood Compensation Authority's update that was circulated on 08 January 2025
The government has confirmed that all projects in the New Hospital Programme will be built.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine aprocitentan (Jeraygo) to treat hypertension (high blood pressure) in adults whose blood pressure cannot be adequately controlled by at…
Alongside ambassador Barry Keoghan, the Foreign Secretary will lead a campaign to advocate for family-based care for all children across the globe.
As with any medicine, the MHRA will keep the safety and effectiveness of seladelpar under close review.
The government commissions the Advisory Council on the Misuse of Drugs (ACMD) to conduct an updated harms assessment of ketamine.
The government's pandemic planning has been stepped up in response to recommendations from the Covid-19 Inquiry Module 1 report.
Fresh guidance will give businesses the green light to sell certain pioneering hearing aids.
A suite of guidance has been published by the Medicines and Healthcare products Regulatory Agency (MHRA).
The Health and Social Care Secretary made a statement to the House of Commons on winter pressures.
£5.5 million to go towards vital research projects to tackle ongoing mpox outbreaks in DRC and neighbouring countries.
Changes to the Misuse of Drugs Act 1971 to control 22 substances, with 2-benzyl benzimidazole variants (nitazenes) falling under a new generic definition.
Ten leading experts have joined the Advisory Council on the Misuse of Drugs (ACMD) to strengthen its vital work advising the government on drug harms.
Scientists at VDEC use ‘organ-on-a-chip’ models to study infections and immune responses, aiming to improve vaccine testing and reduce reliance on animal research.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).